(Q46961792)

26 December 2017

title

Ras mediates cell survival by regulating tuberin (English)

1 reference

26 December 2017

author name string

Freilinger A

1

1 reference

26 December 2017

Rosner M

2

1 reference

26 December 2017

Hanneder M

3

1 reference

26 December 2017

Hengstschläger M

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

8 October 2007

1 reference

26 December 2017

published in

Oncogene

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

14

1 reference

26 December 2017

page(s)

2072-2083

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210844

exact match

0 references

cites work

Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Biphasic behavior of changes in elemental composition during staurosporine-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

The dark side of Ras: regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

PI 3-kinase, Akt and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Ribosomal S6 kinase signaling and the control of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

PI3K/Akt and apoptosis: size matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberin activates the proapoptotic molecule BAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis: from tubers to mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

TSC2: filling the GAP in the mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

The TSC1 gene product, hamartin, negatively regulates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis complex: from Drosophila to human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Akt regulates growth by directly phosphorylating Tsc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

A role of the tuberous sclerosis gene-2 product during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210844

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210844

1 reference

26 December 2017

PubMed ID

17922028

1 reference

26 December 2017